Hepatitis B, Chronic: all 954 studies
Page 7 of 10. Open to participants first (147), then studies with results posted, then the rest; newest registration first within each.
- Tenofovir As Prevention Of Hepatitis b Mother-to-child TransmissionStatus unknownNCT02937779Phase 4
- Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus InfectionActive, not recruitingNCT02932150Phase 2
- HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection PatientsStatus unknownNCT02908763Phase 4
- A Study in Healthy Volunteers and Patients With Chronic Hepatitis BCompletedNCT02908191Phase 1
- A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus （HBV MTCT）in Newborns at High RiskStatus unknownNCT02901418
- Effect of Polyherbal Formulation in Chronic Inactive Carriers of Hepatitis B VirusStatus unknownNCT02899130Not applicable
- A Study to Evaluate Addition of Peginterferon Alfa-2a to Chronic Hepatitis B (CHB) Patients Treated With NAsStatus unknownNCT02894918Phase 4
- The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAgStatus unknownNCT02893124Phase 4
- Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With CHB InfectionStatus unknownNCT02886182
- A Long Term Follow-up Study of Patients From the REP 301 ProtocolCompletedNCT02876419
- The Hepatitis B e-Antigen Negative Disease - Directly Offered Study of Treatment Withdrawal in Patients With e-Antigen Negative Chronic HBV Infection (BeNEG-DO).Active, not recruitingNCT02845401Not applicable
- The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownNCT02838810Phase 4
- EFFORT Further Extension StudyStatus unknownNCT02826070Phase 4
- A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) InfectionTerminatedNCT02826018Phase 1
- Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) AdultsStatus unknownNCT02822547Phase 4
- Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control TrialStatus unknownNCT02817685
- Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 TabletStatus unknownNCT02805738Phase 3
- Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive PatientsStatus unknownNCT02793791Not applicable
- Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside AnaloguesCompletedNCT02792088Phase 3
- Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue TherapyCompletedNCT02791386
- Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis BStatus unknownNCT02774837Phase 4
- Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort StudyCompletedNCT02766933
- The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownNCT02745704Phase 4
- HBsAg Loss Adding Pegylated Interferon in HBeAg-negative PatientsCompletedNCT02743182Not applicable
- Off Treatment Durability in Chronic Hepatitis B With Good Immune ControlCompletedNCT02738554Not applicable
- Study of Antiretroviral Therapy to Prevent HBV Intrauterine InfectionStatus unknownNCT02719808
- A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B VaccineCompletedNCT02693652Phase 1/2
- A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)CompletedNCT02662712Phase 1
- Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected PatientsCompletedNCT02646189Phase 1/2
- Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected PatientsCompletedNCT02646163Phase 1/2
- Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue TherapyCompletedNCT02631096Phase 2
- A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHBStatus unknownNCT02615639Phase 1/2
- Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy VolunteersCompletedNCT02612506Phase 1
- New Strategy Study of Functional Cure of Chronic Hepatitis BStatus unknownNCT02605252Not applicable
- A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)CompletedNCT02604823Phase 4
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B PatientsTerminatedNCT02604355Phase 1
- Use of TDF in Patients With Inactive Chronic Hepatitis B InfectionCompletedNCT02600117Phase 3
- A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis BCompletedNCT02598063Phase 4
- Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC TherapyCompletedNCT02594293Phase 4
- Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir TherapyStatus unknownNCT02589652
- Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® TabletCompletedNCT02589457Phase 1
- Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B PatientsStatus unknownNCT02588937Phase 4
- Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue TherapyCompletedNCT02582333
- Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B PatientsStatus unknownNCT02581033Not applicable
- A Study of PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV)CompletedNCT02570191Phase 4
- A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B PatientsCompletedNCT02569372Phase 1
- Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-FranceCompletedNCT02566148
- REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B InfectionCompletedNCT02565719Phase 2
- An Exploratory Study of RGT Strategy on Optimal NUC-experienced PatientsStatus unknownNCT02560649Phase 4
- Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis BCompletedNCT02533544
- Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis BStatus unknownNCT02532413Phase 4
- Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With BaracludeStatus unknownNCT02523547Phase 4
- Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus InfectionCompletedNCT02511743
- Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the PregnancyStatus unknownNCT02510963Not applicable
- Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues TherapyCompletedNCT02505009Phase 4
- A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic HepatitisCompletedNCT02499562Phase 2
- Effect of RO6871765 and RO7011785 on Immune Response With the Stimulation of Peripheral Blood Mononuclear Cells (PBMCs) in Chinese Healthy Volunteers and Chronic Hepatitis B PatientsTerminatedNCT02498275
- Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis BStatus unknownNCT02482272Phase 4
- Combined Therapy With Peginterferon Alfa-2a With NA in NA-treated HBeAg Positive PatientsStatus unknownNCT02474316Phase 4
- Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis BStatus unknownNCT02463019Phase 4
- Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B SubjectsCompletedNCT02431312Phase 1
- Safety and Tolerability of TG1050: A Dose-finding StudyCompletedNCT02428400Phase 1
- Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon TherapyStatus unknownNCT02412592
- The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor InjectionStatus unknownNCT02412319Phase 4
- Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV PatientsCompletedNCT02401737Phase 1
- A Hepatitis B With Hepatic Steatosis StudyStatus unknownNCT02392598
- A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT02391805Phase 2
- Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B PatientsStatus unknownNCT02387684
- Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B PatientsCompletedNCT02387463
- Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a TreatmentStatus unknownNCT02368288Phase 4
- Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis BStatus unknownNCT02366247Phase 3
- Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis BCompletedNCT02366208Phase 2
- Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a TreatmentStatus unknownNCT02365402Phase 4
- Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) AnaloguesStatus unknownNCT02362490Phase 4
- Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B PatientsCompletedNCT02360592Phase 4
- Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infectionCompletedNCT02355951Not applicable
- Study of ARC-520 in Patient With Chronic Hepatitis B VirusWithdrawnNCT02349126Phase 2
- Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon TreatmentStatus unknownNCT02348502
- TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted ReproductionCompletedNCT02338674Phase 1/2
- Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral AgentsStatus unknownNCT02337127Phase 4
- Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon TreatmentStatus unknownNCT02336399
- A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis BCompletedNCT02332473Phase 2
- Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive PatientsStatus unknownNCT02327715Phase 4
- Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B PatientsStatus unknownNCT02327702Phase 4
- Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis PatientsStatus unknownNCT02327689Phase 4
- Emtricitabine for Naive Child Chinese Chronic Hepatitis B PatientsStatus unknownNCT02327676Phase 4
- Emtricitabine for Naive Chinese Chronic Hepatitis B PatientsStatus unknownNCT02327663Phase 4
- A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)Status unknownNCT02327416Phase 3
- Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult VolunteersCompletedNCT02300688Phase 1
- A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer PatientsWithdrawnNCT02289300Phase 2
- Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis BTerminatedNCT02288208Phase 1
- Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis BStatus unknownNCT02287857Not applicable
- Hepatitis B Patients Under Oral Nucleos(t)Ide Treatment With Intermittent Assessment of Kidney FunctionStatus unknownNCT02267473
- Establishment of Retrospective and Prospective Multicenter Cohort for Chronic Hepatitis BCompletedNCT02263755
- Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B InfectionTerminatedNCT02258581
- Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis BCompletedNCT02249988Phase 2/3
- Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected SubjectsCompletedNCT02202473Phase 4
- An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B StudyCompletedNCT02201407
- Observational Study on Patients With Chronic Hepatitis BStatus unknownNCT02167503
- Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) AssayCompletedNCT02167113